Tune in to the J&J Innovation Podcast series featuring CureMatch’s CEO Stephane Richard. J&J’s host, Caroline Baratz goes in depth to discover more about the people behind innovative companies ushering in the latest trends in healthcare.
Recognized as the “Best AI-based Solution for Healthcare” by AI Breakthrough, an independent organization that recognizes the top companies, technologies, and products in the global Artificial Intelligence (AI) market. The CureMatch precision medicine technology utilizes machine learning features and rules-based decision support to offer ranked combination cancer treatment options and has succeeded in pushing ingenuity to be identified as one of the best AI solutions in 2018.
Jessica Federer Joins Advisory Board to Advance Cancer Cures. Stephane Richard and Jessica Federer to speak at PMLS2018. SAN DIEGO, CA – June 26, 2018 – CureMatch, Inc., a digital precision oncology company bridging the gap between legacy cancer treatments and advances in personalized medicine, announces the addition of Jessica Federer to its advisory board. Ms. […]
SAN DIEGO, CA – June 22, 2018 – CureMatch, Inc. offers results of an artificial intelligence (AI) based cancer study at the WIN Symposium 2018 in Paris, June 25-26. CureMatch Co-founder Razelle Kurzrock, M.D. is the Organizing Committee Co-Chair of this 10th anniversary Worldwide Innovative Networking in Personalized Cancer Research event. CureMatch data scientist, Alexander […]
SAN DIEGO, CA – June 14, 2018: CureMatch wins Metroconnect startup pitchfest. Global expansion to include Center for Oncology in Pediatrics (COP) in Mexico. A $35,000 grant will support foreign market expansion of CureMatch precision oncology technology to improve cancer treatment outcomes around the globe.